Al-Dury S, Wahlström A, Wahlin S, et al. Pilot Study with IBAT Inhibitor A4250 for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis. AASLD 2017, abstract 69.
Europese goedkeuring encorafenib plus cetuximab voor BRAFV600E-gemuteerd mCRC
jun 2020 | Maag-darm-leveroncologie